Gracell Biotechnologies Inc. (Nasdaq: GRCL), a global clinical-stage biopharmaceutical company dedicated to developing highly efficacious and affordable cell therapies for the treatment of cancer, visits the Nasdaq MarketSite in Times Square.
In honor of the occasion, William Cao, PhD, BM, Founder, Chairman & CEO, rings the Opening Bell.